Skip to main content

Advertisement

Log in

Sentinel lymph node biopsy in selected cases of ductal carcinoma in situ

  • Research Articles
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

Abstract

Introduction

Axillary lymphadenectomy is nowadays not recommended to treat ductal carcinoma in situ (DCIS), but there is controversy surrounding the indication for sentinel lymph node biopsy (SLNB).

Materials and methods

A prospective study of a selected group of patients diagnosed preoperatively with DCIS was performed between 2004 and 2009. Indications for SLNB were histologically determined high-grade tumours, tumour size >2 cm and patients scheduled to undergo a mastectomy.

Results

Sixty-five patients were analysed. Surgical technique was mastectomy in 39 patients (60%) and conservative breast surgery in 26 (40%). Definitive histological study of the resected breast tumour revealed 43 cases (66.2%) of DCIS, 15 (23.1%) of ductal invasive carcinoma and seven (10.7%) microinvasive tumours. In confirmed DCIS, only 6.9% of sentinel lymph nodes were positive, in microinvasive carcinoma 28.5% and in invasive carcinoma 40% were positive. Total number of patients with positive sentinel lymph nodes was 11 (16.9%). Of 39 mastectomies, 12 corresponded to microinvasive or invasive carcinoma and six (50%) showed a positive SLNB.

Conclusions

Performing SLNB avoids an unnecessary second surgery to study axillary lymph nodes in invasive carcinoma diagnosed after definitive histological study. In patients undergoing a mastectomy, this study requires an axillary lymphadenectomy that is not useful in up to 50% of cases. We think that in a selected group of patients with DCIS, SLNB improves tumour staging, adapts the treatment and avoids second surgery in this group of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Valenzuela M, Julian TB (2007) Ductal carcinoma in situ: biology, diagnosis and new therapies. Clin Breast Cancer 7:676–681

    Article  CAS  PubMed  Google Scholar 

  2. Veronesi P, Intra M, Vento AR et al (2005) Sentinel lymph node biopsy for localised ductal carcinoma in situ? Breast 14:520–522

    Article  CAS  PubMed  Google Scholar 

  3. Baxter NN, Virnig BA, Dirham SB et al (2004) Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst 96:443–448

    Article  PubMed  Google Scholar 

  4. Rubio IT, Roca I, Sabadell D et al (2009) Beneficio de la biopsia del ganglio linfático centinela en pacientes con carcinoma in situ de mama. Cir Esp 85:92–95

    Article  PubMed  Google Scholar 

  5. Schwartz GF, Giuliano AE, Veronesi U (2002) Proceedings of the Consensus Conference on the Role of Sentinel Lymph Node Biopsy in Carcinoma of the Breast. Cancer 94:2542–2551

    Article  PubMed  Google Scholar 

  6. Piñero A, Gimenez J, Merck B et al (2007) Reunión de consenso sobre la biopsia selectiva de ganglio centinela en el cáncer de mama. Sociedad Española de Senología y Patología Mamaria. Madrid

  7. Yen TW, Hunt KK, Ross MI et al (2005) Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg 200:516–526

    Article  PubMed  Google Scholar 

  8. Intra M, Rotmensz N, Veronesi P et al (2008) Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European institute of oncology on 854 patients in 10 years. Ann Surg 247:315–319

    Article  PubMed  Google Scholar 

  9. Cody III HS (2003) Sentinel lymph node biopsy for breast cancer: does anybody not need one? Ann Surg Oncol 10:1131–1132

    Article  PubMed  Google Scholar 

  10. Pendas S, Dauway E, Giuliano R et al (2000) Sentinel node biopsy in ductal carcinoma in situ patients. Ann Surg Oncol 7:15–20

    Article  CAS  PubMed  Google Scholar 

  11. Veronesi P, Rodriguez-Fernandez J, Intra M (2007) Controversies in the use of sentinel nodes: microinvasion, post surgery and after preoperative systemic treatment. Breast 16:67–70

    Article  Google Scholar 

  12. Sakr R, Barranger E, Antoine M et al (2006) Ductal carcinoma in situ: value of sentinel lymph node biopsy. J Surg Oncol 94:426–430

    Article  PubMed  Google Scholar 

  13. Tunon de Lara C, Giard S, Buttarelli M et al (2008) Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy. Breast J 14: 135–140

    Article  PubMed  Google Scholar 

  14. Berg WA, Gutierrez L, Ness Aiver MS et al (2004) Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 233:830–349

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jaime Ruiz-Tovar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Collado, M.V., Ruiz-Tovar, J., García-Villanueva, A. et al. Sentinel lymph node biopsy in selected cases of ductal carcinoma in situ . Clin Transl Oncol 12, 499–502 (2010). https://doi.org/10.1007/s12094-010-0543-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-010-0543-3

Keywords

Navigation